Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients.

Mahboubeh Fereidan-EsfahaniPaul A DeckerStephen D WeigandAlfonso Sebastian Lopez-ChiribogaEoin P FlanaganJan-Mendelt TillemaClaudia F LucchinettiJeanette E Eckel-PassowWilliam Oliver Tobin

Published in: Annals of clinical and translational neurology (2023)

Most TD patients should be considered part of the MS spectrum after excluding MOGAD and NMOSD. Motor symptoms and older age at presentation portend a poor outcome.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
multiple sclerosis
physical activity
depressive symptoms
sleep quality
community dwelling